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Introduction: : We sought to report the oncologic and functional outcomes of endopelvic fascia (EPF), pubo
prostatic ligaments (PPL), and dorsal venous complex (DVC) preservation with hydrodissection of the neuro
vascular bundles (NVB) during robot-assisted radical prostatectomy (RARP).
Materials and Methods: A retrospective review of our prospectively maintained prostate cancer database was
performed. Patients who underwent bilateral or unilateral nerve sparing were identified. Propensity score
matching was performed in a ratio of 1:1.6 between new technique (Group 1) and a historical group (Group 2).
Data were reviewed for perioperative, oncologic, and functional outcomes. Cumulative incidence curves were
used to depict perfect continence (0 pads), social continence (0-1 pads), and potency (SHIM≥17 with or without
erectile aids). Multivariate models were used to elicit variables associated with continence and potency.
Results: : 76 patients in Group 1 and 126 patients in Group 2 were included. Median follow up was 17 months.
Group 1 showed higher perfect continence rates at 1 month (9% vs 3%), 3 months (24% vs 19%), and 6 months
(54% vs 34%) compared to Group 2 respectively (log rank p<0.01). Group 1 also showed higher social conti
nence rates at 1 month (15% vs 3%), 3 months (77% vs 32%), and 6 months (87% vs 53%) compared to Group 2
respectively (log rank p<0.01). Group 1 had a similar potency rate compared to Group 2 (log rank p=0.25).
Multivariate analysis showed that Group 1 was associated with improved perfect (Possibility ratio (PR) 1.82,
95% CI 1.29–2.58, p<0.01) and social continence (PR 2.54, 95% CI 1.83 – 3.52, p<0.01), but not potency.
Conclusions: : EPF, PPL, and DVC preservation with hydrodissection of the NVB offered similar oncological
outcomes, but earlier and improved urinary continence rates compared to standard dissection.

Introduction
Prostate cancer (PCa) is the most common cancer in men with an
estimated incidence of 191,930 new cases and 33,330 deaths in 2020

[1]. The use of robot-assisted surgery in the treatment of PCa has
significantly expanded owing to improved ergonomics, dexterity, and
3-dimensional vision. In 2009, 70% of radical prostatectomies (RP) in
the US were done with robot-assistance [2 3]. Safety and efficacy of
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robot-assisted radical prostatectomy (RARP) has been confirmed in
multiple studies [4–6]. Like open RP, urinary incontinence and erectile
dysfunction are well established complications, both often lead to sig
nificant ramifications on patients’ quality of life.
As a surgeon’s experience increases, cancer control after RP im
proves, presumably because of improved surgical technique. Recurrence
rates have dramatically dropped from 17.9% to 10.7% with improved
surgical experience [7]. Urinary incontinence after RARP is influenced
by many factors such as baseline urinary function, adequate bladder
capacity, bladder compliance, and the absence of urethral pathology.
Surgical factors include surgeon’s experience and surgical technique
[8]. Preservation of the neurovascular bundle (NVB) has been associated
with improved rates of potency and suggested improvement to urinary
continence [9]. Avoiding thermal or stretch injury to the NVB is key.
Several series have described collateral damage to the NVB from heat
associated with monopolar or bipolar usage as major culprits in
non-expected postoperative urinary incontinence. Various techniques
have been described to reduce these complications, including nerve
sparing (NS), Veil of Aphrodite (Vattikuti Institute Prostatectomy
[VIP]), modified prostate fascia-preserving (veil) nerve sparing or Super
Veil, Retzius sparing, NeuroSAFE, and extended prostatic urethra pres
ervation [10–14].
In 2008, the hydrodissection technique as an athermal technique to
facilitate NVB dissection and preservation during RARP was described
[15]. We sought to review our experience with hydrodissection of the
NVB in addition to endopelvic fascia (EPF), puboprostatic ligaments
(PPL), dorsal venous complex (DVC) preservation presenting a thorough
assessment of the oncologic and functional outcomes.

Table 1
Patient demographics, clinical and intraoperative information.
Non EPF
preservation
Number of Patients,
# (%)
Age, yrs mean ± SD
BMI kg/m2 mean ±
SD
ASA ≥3, # (%)
African American
race, # (%)
Caucasian race, #
(%)
Another race, # (%)
Prostate volume gm,
mean ± SD
CCI, mean ± SD
NCCN high risk, #
(%)
Prior abdominal
surgery, # (%)
Bilateral nerve
sparing, # (%)
Preoperative SHIM,
median (IQR)
Operative time
minutes, median
(IQR)
EBL ml, median (IQR)
Any complications, #
(%)
High grade
complications, #
(%)

Methodology and materials
A retrospective review of our prospectively maintained database was
performed (IRB approval-198211). All patients included were preoper
atively continent and potent (Sexual Health Inventory for Men (SHIM) ≥
17). Patients who were impotent, those who had non-NS RARP, as well
as those with incomplete functional follow up were excluded from the
study.
We incorporated the EPF, PPL, and DVC preservation with hydro
dissection of the NVB starting from October 2017, while the standard
dissection occurs without EPF, PPL, DVC preservation, and without
hydrodissection of the NVB. Patients were divided into 2 groups: the
EPF, PPL, and DVC preservation with hydrodissection of the NVB (Group
1) and those who underwent NS-RARP with standard dissection of NVB
and without EPF, PPL, DVC preservation and without hydrodissection of
the NVB (Group 2) in a ratio of 1:1.6. Both groups were matched using
propensity score in terms of age, race, body mass index (BMI), Charlson
comorbidity index (CCI), American Society of Anesthesiology scores
(ASA), prior abdominal/pelvic surgery, prostate volume, preoperative
SHIM score, NS status and laterality, and National Comprehensive
Cancer Network (NCCN) risk group. All surgeries were performed by a
single surgeon (K.G).
We have illustrated our step-by-step technique by a video demon
stration (Supplementary Video). In brief, the EPF is completely spared
from dissection. The superficial dorsal venous complex (DVC) and
puboprostatic ligaments are encountered and preserved during defattening of the prostate. For preservation of NVB, we used a Cook®
Williams cystoscopic injection needle (Bloomington, Indiana, USA) to
inject 10 ml of saline into the plane between the prostatic pedicle and
the NVB. The NVB was bluntly dissected at the prostate base, and the
vascular pedicle was controlled with Hemolock® clips near the prostate
base. Apical dissection was started after increasing the pneumo
peritoneum pressure to 20 mmHg. The PPL were released and the DVC
was cut using cold scissors. The DVC complex was controlled using a
running 3/0 Vicryl suture [15]. Bladder neck reconstruction was not
performed in any of the cases. Catheter was removed 7-10 days post
operatively. All patients were instructed to perform pelvic floor muscle

Biochemical
recurrence, # (%)
≥pT3
Positive margins, #
(%)
pN+Ve, # (%)
Adjuvant radiation, #
(%)
Zero Pads, # (%)
One security Pad, #
(%)
Postoperative SHIM,
median (IQR)
Postoperative SHIM
≥17, # (%)

EPF
Preservation

All

P
Value

Matched variables
126 (62)
76 (38)

202

61 ± 7
30 ± 5

61 ± 7
30 ± 9

61 ± 7
30 ± 7

0.68
0.99

19 (15)
7 (6)

9 (12)
6 (8)

28 (14)
13 (6)

0.68
0.47

117 (93)

67 (88)

184 (91)

0.47

2 (2)
36 ± 18

3 (4)
39 ± 19

5 (2)
37 ± 18

0.47
0.13

4±1
28 (22)

4±1
18 (24)

4±1
46 (23)

0.89
0.86

44 (35)

28 (37)

72 (36)

0.76

77 (61)

44 (58)

121 (60)

0.66

23
(20,25)

0.944

<
0.01

23 (20,25)

23
(19.5,24.25)
Perioperative Variables
179 (150-201)
133 (117-151)
100 (75-200)

100 (75-200)

26 (21)

16 (21)

160
(130188)
100 (75200)
42 (21)

5 (4)

1 (1)

6 (3)

0.41

Pathological Outcomes
8 (7)
3 (4)

11 (6)

0.54

61 (48)
28 (22)

38 (50)
16 (21)

99 (49)
44 (22)

0.89
1.00

4 (4)
17 (13)

1 (2)
5 (7)

5 (3)
22 (11)

0.66
0.16

Functional Outcomes
80 (65)
59 (80)
101 (82)
70 (95)

139 (71)
171 (87)

0.04
0.02

9 (5,13)

10 (6,16)

9 (6,15)

0.37

39 (40)

32 (47)

71 (43)

0.43

0.93
1

training postoperatively. PDE5Is were recommended as needed prior to
sexual activity.
We utilized the matched cohorts for all statistical analysis. Patient
characteristics were reported using descriptive statistics. Patients were
compared in terms of demographics, perioperative, oncologic, and
functional outcomes. The NCCN definition of biochemical recurrence
were used as a proxy for oncologic outcome. Continence and potency
were assessed at catheter removal (7-10 days postoperatively), 6 weeks,
and every six months postoperatively. The patient was also asked to
report the exact timing of recovery of continence and potency in be
tween these time periods. Urinary continence was assessed using the
University of California at Los Anglos- Prostate cancer index-short form
(UCLA – PCI SF-12 v2) Urinary Function questionnaire. Continence was
stratified into patients who did not require the use of pads at all (perfect
continence) and patients using one pad daily for assurance (social
continence). Potency recovery was evaluated using the SHIM ques
tionnaires. Potency was defined as a SHIM score of 17 or more with or
without the use of phosphodiesterase inhibitors (PDE5Is). Median time
2
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Fig. 1. Kaplan - Meier Curve Depicting Biochemical recurrence free survival (p=0.98).

to urinary continence was reported. Kaplan-Meier curve was used to
depict biochemical recurrence free survival (BRFS). Cumulative inci
dence curves were used to depict urinary continence (perfect and social)
and potency. Multivariate Cox regression models were used to deter
mine variables significantly associated with perfect continence, social
continence, and potency. All tests were 2-sided and statistical signifi
cance was considered as p≤0.05. All statistical analyses were performed
using SAS® (version 9.4, SAS Institute Inc., Cary, NC).

Both groups had a similar median estimated blood loss (p=0.93), and
none of the patients required blood transfusion. Twenty-one percent of
the patients developed complications, 3% developed high-grade com
plications with no statistical difference between both groups. On final
pathology, both groups had similar ≥pT3 (p=0.89), node positive dis
ease (pN+) (p=0.66) and positive soft tissue surgical margins (PSTSM)
(p=1.00) (Table 1). Both groups showed similar BRFS at 12 months
(98% vs 97%) and 24 months (91% vs 93%) for Group 1 vs Group 2,
respectively (log rank p=0.98) (Fig. 1).
Group 1 showed higher perfect continence rates at 4 weeks (9% vs
3%), 3 months (24% vs 19%), and 6 months (54% vs 34%) compared to
Group 2 respectively. Group 1 also showed higher social continence
rates at 4 weeks (15% vs 3%), 3 months (77% vs 32%), and 6 months
(87% vs 53%) compared to Group 2 respectively. The perfect and social
continence rates were significantly higher for Group 1 compared to
Group 2 (log rank p<0.01 for both comparisons) (Fig. 2). Median time
to perfect continence was 5.8 vs 6.4 months (p=0.03) for Group 1 vs
Group 2, respectively. Median time to social continence was 1.9 vs 5.4
months (p<0.01) for Group 1 vs Group 2, respectively. Group 1 showed
higher potency rates at 1 month (2% vs %), 3 months (30% vs 24%), 6
months (35% vs 29%), and 12 months (42% vs 32%) compared to Group
2, respectively. The potency rates did not reach statistical significance

Results
Two hundred and two patients were identified (76 in Group 1 and
126 in Group 2), with a median follow up of 17 months (interquartile
range 6-26 months). Overall mean age was 61 ± 7 years, mean CCI was
4 ± 1 and 14% of the patients had an ASA score (≥3). In terms of NCCN
risk stratification, 46 (23%) were in the high-risk group. Mean prostate
volume was 37 ± 18 gm and mean PSA was 8 ± 6 ng/dl. All patients
were continent and potent preoperatively with a median pre-operative
SHIM score of 23 for both groups. Only 60% of the study cohort un
derwent bilateral NS and the rest underwent unilateral NS. Both groups
were matched in terms of baseline patient and disease characteristics
and in terms of NS status (Table 1).
3
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Fig. 2. (a) Cumulative Incidence rate to 0-1 Pad (p<0.01).
(b) Cumulative Incidence Rate to 0 Pad (p<0.01).

(log rank p=0.25) (Fig. 3).
On multivariate analysis, age was significantly associated with social
continence (Possibility ratio (PR) 0.98, 95% CI 0.95-0.99, p=0.03). High
ASA (≥3) was negatively associated with perfect continence (PR 0.52,
95% CI 0.30 – 0.90, p<0.01). EPF, PPL, and DVC preservation and
hydrodissection of the NVB was significantly associated with perfect (PR
1.82, 95% CI 1.29 – 2.58, p<0.01) and social continence (PR 2.54, 95%
CI 1.83 – 3.52, p<0.01). Preoperative SHIM score was the only predictor
for postoperative potency (PR 1.16, 95% CI, 1.03 – 1.30, p=0.01)
(Table 2).

Thus, technical modifications are continuously proposed to improve
rates and earlier return of continence and potency after RARP. However,
the oncologic safety remains the primary outcome after RARP and
should not be compromised. Also, there is no consensus within the
literature on the best NS technique. The present study reports our
experience with EPF, PPL, and DVC preservation and hydrodissection of
the NVB on postoperative continence and potency. In comparison the
VIP spares the nerve fibers between the 1-o’clock and the 5-o’clock
positions, and between the 6-o’clock and the 11-o’clock positions, but
not between the 11-o’clock position and 1-o’clock position, where the
prostatic fascia is adherent to the capsule. In the Super Veil, dissection is
extended anteriorly, preserving the tissue between 11 and 1-o’clock, the
pubovesical ligaments, and the dorsal venous plexus. Few differences
exist between our technique and both techniques mentioned above. The
VIP utilizes a suture to control the DVC before cutting it. The EPF is not
always preserved in the VIP and Super Veil. Lastly, both the VIP and
Super Veil do not utilize hydrodissection of the NVB. We believe that
hydrodissection helps in the delineation and dissection of the planes and
avoids the need for thermal dissection [13 14 17 18]. Our study has

Discussion
Functional outcomes are critical for maintaining quality of life of
patients after RARP. The objective of RARP has thus expanded to
maximize functional outcomes through technical modifications and
methodological innovations. In 1982, Walsh et al. first postulated the
relation between retention of NVB in the prostatic pedicles and
enhanced continence and erectile function post-operatively [16].
4
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Fig. 2. (continued).

showed that EPF, PPL and DVC preservation and hydrodissection of the
NVB was associated with improved rates and time to continence without
compromising oncologic outcomes.
Hydrodissection is an athermal NS technique. Similar techniques are
used in neurosurgery and in ophthalmic, plastic, and general surgeries to
minimize tissue damage, limit manipulation of the tissue, and enhance
visualization of correct tissue planes. This technique was first described
by Guru et al. on ten patients undergoing NS RARP without reporting
oncologic or functional outcomes [15]. Later, Patel et al. found that
hydrodissection of the NVB during open RP improves postoperative
erectile function and time to intercourse compared with standard
dissection [19]. The technique was reproduced during RARP and has
shown significantly improved erectile function at 6 months and 1 year
after surgery [20]. None of the above studies has assessed oncologic and
continence outcomes. Our study has shown improved time to continence
and rates of continence but failed to demonstrate improved potency
rates. This may be explained as 40% of our patient cohort had only
unilateral NS. Also, the short-term follow-up of our study cohort
compared to historical cohort.
Bladder neck preservation (BNP) has been proposed to accelerate
continence recovery, although this remains controversial [21 22]. In
addition, a large bladder neck reconstruction is time-consuming and
may be more susceptible to anastomotic leak. Freire et al. has compared
BNP versus standard technique during RARP. BNP was associated with

quicker recovery of urinary function and similar cancer control [23].
Our cut down technique of bladder neck dissection was similar between
both groups and was effective where none of our patients required
bladder neck reconstruction.
Retrospective studies investigating EPF preservation showed
improved continence rates following RARP [24–26]. However, a recent
randomized controlled trial investigated EPF preservation showed no
benefit on continence and sexual outcomes [27]. Our study cohort has
showed statistically significant improvement in continence outcomes
and improved sexual function but was not statistically significant. These
improvements may be multifactorial in our study as several changes
were implemented simultaneously. Additionally, other key factors such
as less disturbance of the anatomy, judicious use of cautery may have
also contributed.
Full functional-length urethral sphincter preservation was reported
in 2012 and has shown a statistically significant higher rate of conti
nence at 1 week after catheter removal compared to non-urethral
sparing technique (50% vs 31%, p<0.01). Extended preservation of
the prostatic urethra (EPUP) has been performed by Bragayrac et al. on
48 consecutive patients aiming to improve time to continence. They
compared EPUP vs non-EPUP cohorts. Their immediate continence
(within two days of catheter removal) (0-1 pad) rate was 35% vs 0% for
patients with no EPUP. Continence rates were 67% vs 40% and 83% vs
71% at 7 weeks and 6 months for EPUP vs no EPUP, respectively.
5
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Fig. 3. Cumulative Incidence Time to Potency (SHIM≥17) (p=0.25)

non-in our study. Limited by short term follow up for both studies,
positive margins rates and BRFS were similar [10].
Another study described retrograde release of the NVB with preser
vation of the DVC during RARP on 128 patients by a single surgeon.
Eighty six percent were continent immediately after the catheter
removal and 98% after one year. Fifty three percent of the patients were
potent one month after the procedure and 86% at 1 year. All patients
underwent penile rehabilitation with regular use of PDE5Is starting 7
days after surgery, until recovery of sexual function. This study showed
that anatomical preservation is associated with improved functional
outcomes. Our technique allows for more anatomical preservation by
preserving the PPL and EPF. The reported potency and continence rates
are higher than our study which may be explained by only 60% of our
patients had bilateral NS procedure and penile rehabilitation was not
done routinely for our patients [28].
Retzius sparing (RS) RARP has been introduced to improve the time
to continence. A propensity score matched study between RS-RARP and
conventional RARP has shown a higher continence rate at 1-month (45%
vs 9%) and 6-month (98% vs 77%) for RS-RARP. Also, RS-RARP had a
significantly shorter operative time (149 mins vs 194 mins) [29].
RS-RARP seems to provide earlier continence rates but the differences
diminish at 6 months and longer follow up [30]. The posterior approach
was not found to have any advantage regarding time to potency and
potency rates [30]. Despite these advantages, adoption of RS technique

Table 2
Multivariate Cox model to elicit predictors of continence and potency.
Variable

Possibility
Ratio

Age
EPF, PPL and DVC
preservation with
hydrodissection of the
NVB

0.98
2.54

Social Contienence (0-1 pad)
0.95
1.00
0.03
1.83
3.52
<0.01

ASA ≥3
EPF, PPL, and DVC
preservation with
hydrodissection of the
NVB

0.51
1.82

Perfect Conteience (0 pad)
0.30
0.90
0.02
1.29
2.58
<0.01

Preoperative SHIM

Lower
CI

Potency (SHIM≥17)
1.16
1.03

Upper
CI

1.30

Pvalue

0.01

EPF: Endopelvic fascia, PPL: Puboprostatic ligamnet, DVC: Dorsal venous com
plex, NVB: Neurovascular bundle, SHIM: Sexual health inventory for men.

Continence rates at 6 months did not significantly differ between both
groups. Our social continence rates were 87% at 6 months which is
higher than EPUP cohort at 6 months. 4% of the EPUP cohort developed
an anastomotic leak and 4% required blood transfusion compared to
6
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remains limited. The main advantage of RS is preservation of key
anatomical structures, such as PBL, which may improve recovery of
continence. Similar to RS, our technique spares key anatomical struc
tures, and is likely easier to adopt.
Rocco stitch was introduced in 2007 and has shown improved time
and continence rates [31]. An update from Patel et al. utilized the Rocco
stitch and prospectively analyzed 331 patients who underwent RARP, 94
without the placement of a suspension stitch (group 1) and 237 with the
application of the suspension (puboperiurethral) stitch (group 2). In
group 1, the continence rate at 1, 3, 6, and 12 months postoperatively
was 33%, 83%, 94.7%, and 95.7%, respectively; in group 2, the conti
nence rate was 40%, 92.8%, 97.9%, and 97.9%, respectively. The sus
pension technique resulted in significantly greater continence rates at 3
months after RARP (p=0.01). The median interval to recovery of
continence was also significantly shorter in the suspension group (me
dian: 6 weeks) versus the non-suspension group (median: 7 weeks, p =
0.02) [32]. The suspension stitch seems to improve time to and conti
nence rates by restoring pelvic floor anatomy.
The current study has several limitations, including the retrospective
study design, relatively small sample size and short follow up. The grade
of nerve preservation (intrafascial, interfascial and extrafascial) was not
captured by our database. Also, several modifications were implemented
at once which limits the conclusion about each step.
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